Oryzon Genomics S.A. (BME:ORY)

Oryzon Genomics Balance Sheet

Financials in millions EUR. Fiscal year is January - December.

Fiscal Year	TTM	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020
Period Ending	Jun 30, 2025	Dec 31, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021	Dec 31, 2020
Cash & Equivalents	31.11	5.62	12.26	21.32	28.72	39.6
Cash & Short-Term Investments	31.11	5.62	12.26	21.32	28.72	39.6
Cash Growth	208.78%	-54.16%	-42.50%	-25.79%	-27.47%	12.35%
Other Receivables	2.98	3.11	2.01	3.84	3.78	2.46
Receivables	2.98	3.11	2.01	3.84	3.78	2.46
Inventory	0.01	0	0.01	0.01	0.1	0.32
Other Current Assets	0.04	0.02	0	-	-	0
Total Current Assets	34.14	8.75	14.28	25.16	32.61	42.38
Property, Plant & Equipment	0.31	0.36	0.48	0.61	0.68	0.64
Long-Term Investments	-	-	-	-	-	0.04
Other Intangible Assets	0.26	0.22	0.38	0.52	0.63	0.21
Long-Term Deferred Tax Assets	2.42	2.39	2.22	2.05	1.81	1.8
Long-Term Deferred Charges	101.09	96.87	89.51	75.32	59.62	49.01
Other Long-Term Assets	0.13	0.13	0.03	0.03	0.03	0.03
Total Assets	138.35	108.72	106.9	103.7	95.38	94.11
Accounts Payable	2.1	2.13	3.41	5.06	2.91	2
Accrued Expenses	1.11	0.58	0.6	0.54	1.24	0.62
Short-Term Debt	-	-	-	-	-	0.14
Current Portion of Long-Term Debt	9.4	8.74	11.92	12.17	4.17	4.71
Current Portion of Leases	0.02	0.02	0.02	0.02	-	-
Other Current Liabilities	0.36	0.27	0.46	0.93	0.35	0.22
Total Current Liabilities	13.01	11.74	16.41	18.73	8.67	7.69
Long-Term Debt	8.67	7.42	6.28	10.27	13.35	8.68
Long-Term Leases	0.02	0.03	0.06	0.08	-	-
Long-Term Deferred Tax Liabilities	2.42	2.39	2.22	2.05	1.81	1.8
Other Long-Term Liabilities	-	-	0.15	-	-	-
Total Liabilities	24.13	21.67	25.13	31.13	24.12	18.18
Common Stock	3.93	3.29	3.06	2.78	2.65	2.65
Additional Paid-In Capital	130.08	100.71	92.38	79.69	73.96	73.96
Retained Earnings	-20.88	-19.29	-15.62	-12.27	-8.04	-3.35
Treasury Stock	-2.03	-2.03	-0.55	-0.62	-0.69	-0.69
Comprehensive Income & Other	3.13	4.36	2.51	3	3.38	3.36
Shareholders' Equity	114.22	87.04	81.77	72.57	71.26	75.93
Total Liabilities & Equity	138.35	108.72	106.9	103.7	95.38	94.11
Total Debt	18.12	16.21	18.27	22.54	17.52	13.53
Net Cash (Debt)	12.99	-10.59	-6.02	-1.22	11.2	26.07
Net Cash Growth	-	-	-	-	-57.02%	18.46%
Net Cash Per Share	0.17	-0.16	-0.10	-0.02	0.21	0.49
Filing Date Shares Outstanding	77.51	64.75	60.88	55.29	52.76	52.76
Total Common Shares Outstanding	77.51	64.75	60.88	55.29	52.76	52.76
Working Capital	21.13	-2.99	-2.14	6.43	23.93	34.68
Book Value Per Share	1.47	1.34	1.34	1.31	1.35	1.44
Tangible Book Value	113.96	86.82	81.39	72.05	70.63	75.72
Tangible Book Value Per Share	1.47	1.34	1.34	1.30	1.34	1.44
Machinery	1.62	1.62	1.62	1.64	1.6	1.56

Updated Feb 27, 2025. Source: S&P Global Market Intelligence. Standard template. Financial Sources.